Collaboration Details

Print  Close


Title of Collaborative Activity:

Longitudinal Study of Implantable Cardioverter-Defibrillators

Description of Collaborative Activity:

After randomized controlled trials demonstrated that implantable cardioverter-defibrillators (ICDs) reduce the risk of death in patients with left ventricular systolic dysfunction. The use of implantable cardioverter-defibrillators (ICDs) for primary prevention increased after randomized controlled trials demonstrated that they reduce the risk of death in patients with left ventricular systolic dysfunction. However, the extent to which the clinical characteristics and long-term outcomes of unselected, community-based patients with left ventricular systolic dysfunction undergoing primary prevention ICD implantation in a real-world setting compare with those of participants enrolled in the randomized, controlled trials is not well characterized. To address the issue, this study is being conducted in the Cardiovascular Research Network, in collaboration with AHRQ.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2011

NIH Participating Institutes/Centers/Office of the Director:

NHLBI

HHS Agency Collaborators on this Activity:

AHRQ